Core Viewpoint - The stock of Kaili Medical (300633) closed at 27.65 yuan on December 1, 2025, with a slight increase of 0.04% and a trading volume of 31,800 hands, amounting to a total transaction value of 87.98 million yuan [1] Group 1: Stock Performance and Trading Data - On December 1, 2025, the net inflow of main funds was 2.69% of the total transaction value, while retail investors experienced a net outflow of 2.3% [1] - Over the past five days, the stock has shown fluctuating trading patterns, with significant net outflows from main funds on November 28 and November 27, and a notable net inflow on November 26 [2] Group 2: Financial Metrics and Industry Comparison - Kaili Medical's total market capitalization is 11.964 billion yuan, which is higher than the industry average of 11.157 billion yuan, ranking 26th out of 124 in the medical device industry [3] - The company's net profit for the first three quarters of 2025 was 33.51 million yuan, reflecting a year-on-year decline of 69.25%, while the main revenue increased by 4.37% to 1.459 billion yuan [3] - The gross profit margin of Kaili Medical stands at 60.36%, significantly higher than the industry average of 51.22%, indicating strong profitability despite lower net profit margins [3] Group 3: Analyst Ratings and Target Price - In the last 90 days, 17 institutions have rated the stock, with 12 buy ratings and 5 hold ratings, indicating a generally positive outlook [4] - The average target price set by analysts over the past 90 days is 40.07 yuan, suggesting potential upside from the current trading price [4]
股票行情快报:开立医疗(300633)12月1日主力资金净买入236.63万元